Australia TGA ARTG recordOral/enteral syringe, reusable
Australia TGA ARTG Registered Device · Accelera Biopharma Pty Ltd · ROVIPHARM · Class Im · Started June 20, 2024
Good Name: Accelera Biopharma Pty Ltd - Oral/enteral syringe, reusable
- Risk Class
- Class Im
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 20, 2024
- Effective Date
- June 20, 2024
- Name
- ROVIPHARM
- Country
- France
- Address
- ZA de Lucinges 86 Route du Plan d'Eau, Treffort, Val-Revermont, 01370
To accurately administer the correct dose of the oral liquid drugs for human use
Access comprehensive regulatory information for Oral/enteral syringe, reusable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class Im is sponsored by Accelera Biopharma Pty Ltd, manufactured by ROVIPHARM in France. The device registration started on June 20, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.